1.
Morocco:
Capital:
Rabat
Morocco is increasingly becoming an important
industrial player in the EMEA region due to its
location as it serves as a stepping stone to Africa and
the Middle East. Having experienced an average
growth of 4.4% in its GDP over the last 15 years, there
are strong indications that its economic growth will
continue to improve.
Population:
34.3 Million
Currency:
Moroccan Dirham
Exchange Value in USD:
1000 Moroccan Dirham equivalent to 108.26 USD
GDP (Purchasing Power Parity)
$298.6 billion (2017 est.)
GDP per capita (Purchasing Power Parity)
$8,600 (2017 est.)
Official Language:
Arabic official language, preferred foreign language is French.
Destination Sea Port or Airport:
Mohammed V International Airport (IATA: CMN) is the largest airport in Morocco.
International Borders/Surrounding Countries:
Morocco is a country in northern Africa.
North - Mediterranean Sea
West – Atlantic ocean
East – Algeria
South – Western Sahara
Morocco shares maritime borders with 14 countries.
Pharma Market Value:
Morocco market had just above ~1.1 Bn sales in 2018.
Sanofi with $93Mn sales is the leading player, local company Bottu S.A’s Doliprane
(paracetamol) with $56Mn sales is the top selling brand and Polymedic (b. $16 M) with 17%
PPG is the fastest growing corporation.
Market Share:
Healthcare Budget:
Healthcare spending
165
160
155
150
145
140
2015 2016 2017
Healthcare spending
Market Growth:
Average growth of 5% last year.
FDA:
Regulatory procedures are under the control of the Drugs and Pharmaceutical
Directorate of the Ministry of Health. The latter is divided into three subdirections:
Division of Pharmacy (responsible inter alia of clinical drug evaluation,
registration and pricing where appropriate);
Pharmaceutical sector monitoring department (e.g. scheduling inspections in
order to establish GMP certificate)
LNCM which is responsible of the quality review of pharmaceutical
documentations as well as of lab-testings.
Registration Time:
The average time to obtain a certificate of registration is six months.
Validity of Registration:
Registration Fees:
Type of Dossier:
In Morocco, the dossier can be submitted in CTD format.
Name of Tender Body:
Indian Pharma Companies:
Sun Pharma is one of the fastest growing pharmaceutical companies in Morocco and
currently market 19 brands across the anti-infective, neuro-psychiatry, cardiovascular,
urology and critical care therapeutic areas. They started their manufacturing
operations in Casablanca in March 2012.
Significant points:
Morocco is among the North African countries benefiting from a higher
political stability, a liberal economy and an educated workforce; practically,
all important elements in order to attract foreign investments.
This is paralleled, in the pharmaceutical and healthcare areas, by the
liberalisation of the capital stock of pharmaceutical companies and, from the
regulatory perspective, from a reform that took place in 2006 aimed to
improve the compliance to ICH recommendations and international quality
standards for manufacturing of medicinal products.
Prices of medicines have also been repeatedly reduced in the period 2010-
2016, a possible element lowering the appeal of the country for foreign
investors. A new price decree was adopted by government in December 2013
comparing ex-factory prices of countries of reference (France, Spain, Portugal,
Saudi Arabia, Turkey, Belgium, and the country of origin when it is different
from the mentioned list).
70% population goes to public hospital.
Characteristics of the market:
Steadily growing population.
Strategic location in northern Africa facilitates access to markets around the
EMEA region, with direct manufacturing operations that serve sub-Saharan
Africa there. Morocco is an ideal region to serve Egypt, Algeria and other
emerging markets in the region.
Price competitiveness, high skilled workforce
Developed infrastructure.
Disease Burden:
Selected Adult Risk Factor Trends:
Top therapy areas:
Causes of Death and Disability compared with other locations:
Disease trend and Risk factors:
Important links:
1. https://2016.export.gov/industry/health/healthcareresourceguide/eg_main_108604.asp
2. https://www.ijsr.net/archive/v5i11/ART20162892.pdf
